These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The pathogenesis of idiopathic hypercalciuria: evidence for renal tubular calcium leak. Muldowney FP, Freaney R, Ryan JG. Q J Med; 1980 Dec; 49(193):87-94. PubMed ID: 7433629 [Abstract] [Full Text] [Related]
25. Familial hypocalciuric hypercalcaemia and acute pancreatitis. Davies M, Klimiuk PS, Adams PH, Lumb GA, Large DM, Anderson DC. Br Med J (Clin Res Ed); 1981 Mar 28; 282(6269):1023-5. PubMed ID: 6783229 [Abstract] [Full Text] [Related]
26. Familial hypocalciuric hypercalcemia: description of a new kindred with emphasis on its difference from primary hyperparathyroidism. Gilbert F, D'Amour P, Gascon-Barré M, Boutin JM, Havramkova J, Bélanger R, Matte R. Clin Invest Med; 1985 Mar 28; 8(1):78-84. PubMed ID: 2985312 [Abstract] [Full Text] [Related]
27. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L. Clin Endocrinol (Oxf); 2008 Nov 28; 69(5):713-20. PubMed ID: 18410554 [Abstract] [Full Text] [Related]
28. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism. Horowitz M, Wishart JM, Need AG, Morris HA, Nordin BE. Horm Metab Res; 1994 Jan 28; 26(1):39-42. PubMed ID: 8150422 [Abstract] [Full Text] [Related]
29. Familial hypocalciuric hypercalcaemia: a study of four kindreds. Toss G, Arnqvist H, Larsson L, Nilsson O. J Intern Med; 1989 Mar 28; 225(3):201-6. PubMed ID: 2703801 [Abstract] [Full Text] [Related]
33. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L. Scand J Urol Nephrol Suppl; 1981 Apr 05; 61():II:1-26. PubMed ID: 6274002 [Abstract] [Full Text] [Related]
34. Familial hypocalciuric hypercalcaemia: a review. Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Curr Opin Endocrinol Diabetes Obes; 2011 Dec 05; 18(6):359-70. PubMed ID: 21986511 [Abstract] [Full Text] [Related]
35. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Glendenning P, Gutteridge DH, Retallack RW, Stuckey BG, Kermode DG, Kent GN. Aust N Z J Med; 1998 Apr 05; 28(2):173-8. PubMed ID: 9612524 [Abstract] [Full Text] [Related]
36. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate. Weissglas M, Löwik C, Schamhart D, Theuns H, Kurth KH, Papapoulos S. BJU Int; 2007 Jun 05; 99(6):1530-3. PubMed ID: 17428243 [Abstract] [Full Text] [Related]
37. Influence of 1,25-dihydroxycholecalciferol on parathyroid activity in patients with primary hyperparathyroidism. Holmlund D, Boquist L, Larsson SE, Lorentzon R. Acta Chir Scand; 1979 Jun 05; 145(1):27-33. PubMed ID: 433514 [Abstract] [Full Text] [Related]
38. [Familial hypercalciuric hypercalcemia]. Kassem M, Eriksen EF, Mosekilde L. Nord Med; 1991 Jun 05; 106(4):107-8, 111. PubMed ID: 2038554 [Abstract] [Full Text] [Related]
39. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Ralston SH, Fogelman I, Gardner MD, Dryburgh FJ, Cowan RA, Boyle IT. Clin Sci (Lond); 1984 Feb 05; 66(2):187-91. PubMed ID: 6692653 [Abstract] [Full Text] [Related]
40. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. Pak CY, Oata M, Lawrence EC, Snyder W. J Clin Invest; 1974 Aug 05; 54(2):387-400. PubMed ID: 4367891 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]